Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhoenix Group Holdings Regulatory News (PHNX)

  • There is currently no data for PHNX

Board Change

14 Mar 2025 09:00

RNS Number : 7347A
Phoenix Group Holdings PLC
14 March 2025
 

LEI: 2138001P49OLAEU33T68

 

14 March 2025

 

Phoenix Group Holdings plc

Board Change

 

Phoenix Group Holdings plc ("Phoenix") today announces the appointment of Sherry Coutu CBE to its Board of Directors as an independent Non-Executive Director and member of the Remuneration Committee with effect from 1 May 2025.

 

Sherry Coutu CBE is an experienced Non-Executive Director, working with a combination of technology, investment, innovation, education and financial services organisations that empower their customers. She is currently Non-Executive Director of Pearson plc, where she is Chair of the Remuneration Committee and member of the Nomination & Governance Committee. At Raspberry Pi plc, she is Senior Independent Director, Chair of the Remuneration Committee and member of the Audit and Sustainability Committees.

 

She brings rich experience as a Non-Executive Director, having previously served on the boards of London Stock Exchange Group plc, RM plc, Zoopla plc and Interactive Investor plc, where she was also Chair of their Remuneration Committees. She spent her executive career as a successful investor and entrepreneur within the technology sector and has impressive credentials gained by investing in, and supporting, numerous companies in their transformation journeys. Over the past 23 years Sherry has made angel investments in more than 70 companies and holds investments in 5 venture capital firms. She has been an angel investor in companies such as leso, 5minsAI, Closed Loop Medicine, Maven, LOVEFiLM, Duedil, LinkedIn, Bonobos and others.

 

Commenting on the appointment, Sir Nicholas Lyons, Chair of Phoenix said:

"We are delighted that Sherry has agreed to join the Board and become a member of the Remuneration Committee of Phoenix Group Holdings plc. She has an impressive career in Technology, AI and a variety of sectors with a customer and digital focus that is welcomed by the Board. Sherry remains an active investor and board director on many technology companies' boards. Her extensive FTSE 100 Remuneration Committee experience will also prove invaluable. We look forward to her diversity of thought at our meetings."

 

This announcement is made pursuant to LR 6.4.6 of the Listing Rules.

 

There is no further information required to be notified under Listing Rule 6.4.8 with regard to Sherry Coutu CBE's appointment referred to above.

 

Enquiries:

Media

Shellie Wells, Corporate Communications Director, Phoenix Group

+44 (0) 204 559 3031

Investors

Claire Hawkins, Director of Corporate Affairs & Brand, Phoenix Group+44 (0) 204 559 3161

Colette CahillAssociate Director, Teneo

+44 (0) 7500 547034

 

Joanne Roberts, Investor Relations Director, Phoenix Group

+44 (0) 204 559 4673

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUSVWRVNUOARR
Date   Source Headline
24th Feb 20262:25 pmRNSChange of Company Name
18th Feb 20262:12 pmRNSAppointment of Corporate Broker
6th Feb 20261:52 pmRNSDirector/PDMR Shareholding
2nd Feb 202611:02 amRNSTotal Voting Rights
6th Jan 20261:31 pmRNSDirector/PDMR Shareholding
2nd Jan 202611:06 amRNSTotal Voting Rights
18th Dec 20252:38 pmRNSCompletion of Redemption at Maturity
18th Dec 20252:38 pmRNSCompletion of Redemption at Maturity
12th Dec 20252:49 pmRNSBlock listing Return
8th Dec 202511:08 amRNSDirector/PDMR Shareholding
1st Dec 20251:57 pmRNSTotal Voting Rights
24th Nov 20255:20 pmRNSBlock Listing Application
24th Nov 20257:09 amRNSLIST 2025 Results Show Robust Capital Position
6th Nov 20253:47 pmRNSDirector/PDMR Shareholding
3rd Nov 202512:01 pmRNSTotal Voting Rights
31st Oct 20253:10 pmRNSDirector/PDMR Shareholding
7th Oct 20251:20 pmRNSDirector/PDMR Shareholding
1st Oct 202512:38 pmRNSTotal Voting Rights
17th Sep 20252:40 pmRNSPublication of a Supplementary Prospectus
10th Sep 20252:51 pmRNSDirector/PDMR Shareholding
8th Sep 20255:23 pmRNSDirector/PDMR Shareholding
8th Sep 20257:00 amRNS2025 Interim Results
1st Sep 202510:00 amRNSTotal Voting Rights
18th Aug 202510:00 amRNSBoard Changes
6th Aug 202512:53 pmRNSDirector/PDMR Shareholding
1st Aug 202510:18 amRNSTotal Voting Rights
8th Jul 20253:31 pmRNSDirector/PDMR Shareholding
1st Jul 202512:26 pmRNSTotal Voting Rights
26th Jun 20259:00 amRNSBoard Changes
13th Jun 20253:00 pmRNSPublication of Prospectus
12th Jun 20252:43 pmRNSBlock listing Return
9th Jun 202512:25 pmRNSDirector/PDMR Shareholding
2nd Jun 202512:44 pmRNSTotal Voting Rights
23rd May 20253:02 pmRNSDirector/PDMR Shareholding
20th May 202510:00 amRNSDirector Declaration
13th May 20253:34 pmRNSResult of AGM
7th May 20254:20 pmRNSDirector/PDMR Shareholding
1st May 202510:33 amRNSTotal Voting Rights
10th Apr 20252:37 pmRNSDirector/PDMR Shareholding
8th Apr 20253:10 pmRNSDirector/PDMR Shareholding
3rd Apr 20251:35 pmRNSNotice of AGM
1st Apr 20252:52 pmRNSDirector/PDMR Shareholding
1st Apr 20252:42 pmRNSTotal Voting Rights
26th Mar 20253:46 pmRNSDirector/PDMR Shareholding
24th Mar 20255:43 pmRNSDirector/PDMR Shareholding
21st Mar 202511:56 amRNSDirector/PDMR Shareholding
20th Mar 20254:19 pmRNSDirector/PDMR Shareholding
19th Mar 20254:26 pmRNSDirector/PDMR Shareholding
19th Mar 20252:15 pmRNSDirector/PDMR Shareholding
17th Mar 20257:00 amRNS2024 Annual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.